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TOBACCO - GENE ACTIVITY PROFILES IN PORPHYROMONAS GINGIVALIS, 
   FILIFACTOR ALOCIS AND TREPONEMA DENTICOLA 
 
Neelima Chowdary Cherukumalli, BDS 
April 18, 2016 
 
Smoking is an established risk factor for periodontitis. Prior studies have shown 
that cigarette smoke extract (CSE) can induce profound phenotypic changes in 
Porphyromonas gingivalis and alters the virulence of this important periodontal 
pathogen. We hypothesized that CSE might also alter gene expression in 
established periodontal pathogens, Porphyromonas gingivalis and Treponema 
denticola, as well as in the emerging pathogen, Filifactor alocis. Oral bacteria were 
grown in CSE-conditioned medium (1000 ng/ml nicotine equivalents) or in 
unconditioned control medium. Total RNA was extracted and CSE-regulated 
genes were identified by comparison of the mRNA profiles of CSE with control 
cultures using RNA-Seq analysis. Approximately, 30% of genes in the P. gingivalis 
genome and 5% of genes in the F. alocis genome were found to be differentially 
expressed when exposed to cigarette smoke. Several genes responsible for DNA 
replication and repair, transfer (tra) genes, ABC transporter genes and several 
metabolic genes were found to be differentially expressed in both F. alocis and P.
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gingivalis. Validation of RNA-Seq differentially expressed genes was done by 
qPCR analysis for selected genes and similar results were found. More in depth 
study of these genes could provide some of the first insights into how cigarette 
smoke changes the P. gingivalis and F. alocis phenotype in a manner likely to 
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CHAPTER 1:  INTRODUCTION 
 
Tobacco and Disease 
 Tobacco is the single biggest preventable reason for death and illness in 
the United States. According to the World Health Organization, there were around 
1.3 billion smokers worldwide in 2003, and that number is relied upon to increment 
to 1.7 billion by 2020 (1). Cigarette smoking kills more than 480,000 Americans 
each year, with more than 41,000 of these deaths from exposure to secondhand 
smoke (2). In addition, smoking-related illness in the United States costs more than 
$300 billion a year (2, 3). 
 Cigarette smoke is a complex mixture of chemical compounds. 
Researchers have estimated that cigarette smoke has > 7000 chemical 
compounds from many different classes (4). Components of smoke are contained 
in either the particulate phase or the gas phase. The particulate phase ingredients 
include tar, polynuclear hydrocarbon phenol, cresol, catechol and trace elements 
which are carcinogens; indol, carbazole (tumor accelerators) and 4-aminobiphenyl 
(known to cause hepatocellular carcinoma) (5). The gas phase contains carbon 
monoxide, hydrocyanic acid, acetaldehyde, acrolein, ammonia, formaldehyde and 
oxides of nitrogen, nitrosamines, hydrazine, and vinyl chloride that have 
carcinogenic activity (6,7,8,9). Nicotine in cigarette smoke is highly addictive. In 
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little doses nicotine goes about as a stimulant to the brain. In substantial doses, 
it's a depressant, repressing the signals between nerve cells. In considerably 
bigger doses, it's a deadly toxic substance, influencing the heart, veins, and 
hormones (10). 
 There is a positive association between tobacco smoking and cancers of 
the lung, oral cavity, pharynx, larynx, esophagus, pancreas, bladder, kidney, 
pelvis, nasal cavities, paranasal sinuses, nasopharynx, liver, stomach, kidney and 
cervix (12). Smoking accounts for at least 30% of all cancer deaths and 87% of 
lung cancer deaths. In the United states, tobacco use is responsible for nearly 1 in 
5 deaths (11). In 2012, the estimated percentage of new lung cancers in males 
and females was 14% each. Among these lung cancers, 29% of male and 26% of 
female cases were estimated to be fatal (11). 
Smoking and Infectious diseases 
 Smokers are more susceptible to multitude of infectious diseases compared 
to non-smokers (13). These include respiratory tract infections, pneumonia, 
tuberculosis, meningitis, sexually transmitted bacterial infections and bacterial 
induced periodontal diseases (14-20). The specific mechanisms by which cigarette 
smoking increases the risk of systemic infections are incompletely understood. 
They are multifactorial and can be due to Mechanical and Structural or 
Immunologic changes caused by smoking (21). Cigarette smoke and many of its 
components like acrolein, acetaldehyde, formaldehyde, free radicals and nitric 
oxide, are believed to be responsible for structural alterations in the airway 
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epithelial cells, which is thought to predispose to the development of upper and 
lower respiratory tract infections (22,23). 
 Cigarette smoking alters various cellular and humoral immune system 
functions. These alterations include a (i) decreased level of circulating 
immunoglobulins. Several studies have found that smokers had serum 
immunoglobulin levels (IgA, IgG, and IgM) 10% to 20% lower than those of 
nonsmokers (24-27), (ii) depression of antibody responses to certain antigens, 
such as influenza virus infection (28) and Aspergillus fumigatus infection (29), (iii) 
decrease in CD4+ lymphocyte counts, an increase in CD8+ lymphocyte counts. 
Since CD4+ cells facilitate B-cell proliferation and differentiation and 
immunoglobulin synthesis, decrease in the CD4 count seen in heavy smokers (≥ 
50 pack-year) might contribute to the increased susceptibility to infections in this 
population. Increase in CD8+ cells in heavy smokers (≥50 pack-year) has also 
been found to be associated with infection (30,31,32), (iv) depressed phagocyte 
activity. There is reduced migration and chemotaxis of Polymorphonuclear 
leukocytes in the peripheral blood of smokers compared with PMNs from 
nonsmokers (33,34). Also motility and chemotaxis of PMNs are depressed in the 
oral cavity of smokers compared with nonsmokers (33), and (v) decreased release 
of proinflammatory cytokines. The release of cytokines from macrophages may 




Figure 1: Diseases related to smoking 
Image showing association between smoking and various cancers and chronic 
diseases. The conditions in red are the new diseases that have been linked to 
smoking in the 2014 report by surgeon general and conditions in black are linked 
to smoking by USDHHS in 2004, 2006 and 2012. 
Photo courtesy of: U.S. Department of Health and Human Services (USDHHS). The Health Consequences of Smoking—
50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): U.S. Department of Health and Human Services, 
Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office 
on Smoking and Health, 2014. 
Smoking and chronic inflammatory diseases 
 Tobacco smoking is known to substantially increase the risk for chronic, 
inflammatory diseases (14,15,37,38), such as acute vascular diseases (40,41), 
inflammatory bowel disorders (42,43) renal disease (15), pancreatitis (16) and 
periodontal diseases (44). Smoking is a major cause of cardiovascular diseases 
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and the risk for these diseases increases with the quantity of cigarettes smoked 
per day and the duration of smoking history (2). Chemicals in cigarette smoke can 
increase vascular permeability and activate adhesion molecule expression, 
resulting in increased leukocyte adhesion and, eventually, platelet aggregation. 
This can narrow the blood vessels and lead to cardiovascular conditions like 
atherosclerosis, acute myocardial infarction and stroke (45,46). Also, smoking 
increases blood pressure and decreases tolerance to exercise (46). 
 Smoking increases risk for lung diseases like chronic bronchitis (47,48), a 
long-term inflammation of the bronchi (large airways). The chemicals in cigarette 
smoke irritate and activate macrophages and epithelial cells. This causes the cells 
to release multiple types of cytokines which lead to thickening and inflammation of 
the airway lining. This persistent inflammation caused by cigarette smoke can 
change the structure of the airways and make them narrower through a cycle of 
injury and repair (49). Smoking is also associated with other chronic inflammatory 
renal diseases like inflammatory bowel disease and chronic kidney disease 
(50,51). 
Periodontal diseases 
 Periodontal diseases are one of the most predominant diseases all through 
the world (52). They represent a group of infectious inflammatory diseases 
affecting the supporting and surrounding tissues of teeth (53). They are second to 
dental caries as a cause of tooth loss among adults in developed countries (54), 
affecting 47.2% adults aged 30 years and older in the US (55). Periodontal 
diseases happen as a consequence of mixed microbial infections within which 
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specific groups of bacteria coexist. In a healthy mouth there are more than 350 
species of microorganisms and periodontal infections are linked to less than 5% of 
these organisms (56). Porphyromonas gingivalis, Treponema denticola, Prevotella 
intermedia, Aggregatibacter actinomycetemcomitans, Tannerella forsythia, and 
Fusobacterium nucleatum are believed to play prominent roles in the etiology of 
periodontal diseases (56). Recent studies have identified a wide range of bacteria 
associated with disease status like Filifactor alocis, Selenomonas, Synergistes, 
Desulfobulbus and TM7 (57,58). These bacteria exist as an organized biofilm on 
the tooth surface. Extension of the biofilm into the gingival sulcus begins a series 
of events that mediate periodontal disease (59). 
 In the gingival sulcus, pathogenic bacteria and their metabolic products 
initiate the inflammatory response in host cells (neutrophils, epithelial cells and 
macrophages). This results in an influx of an inflammatory infiltrate which is rich in 
neutrophils. These neutrophils attempt to phagocytose the bacteria (60). However, 
some periodontal pathogens have developed ways to resist phagocytosis using 
virulence factors like capsules, or avoid phagocytosis by gaining entry into host 
cells (61). Another method of fighting periodontal pathogens is neutrophil 
degranulation. When neutrophils degranulate, they release granular enzymes 
such as elastase, and matrix metalloproteinases (MMPs) as well as superoxide 
and oxygen radicals, and nitric oxides. These products do not discriminate 
between the bacteria and the host tissues. Thus, periodontal tissue destruction will 
result from prolonged exposure (62). 
Smoking and periodontal diseases  
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 Compared to non-smokers, tobacco smokers are more susceptible to 
plaque-induced gingivitis and periodontitis. There is a negative, dose-dependent 
relationship between smoking and periodontal health (63,64). Smokers are also 
more refractory to periodontal treatment than non-smokers (64).  
 Smoking has been shown to affect various aspects of the host immune 
response. It has adverse effects on fibroblast function (65), chemotaxis and 
phagocytosis by neutrophils (66), and immunoglobulin production (67). 
Macrophages play important roles in both cell mediated and humoral immunity as 
antigen-presenting cells. However, antigens are presented in the context of class 
1 major histocompatibility complex (MHC) surface molecules. There might be a 
gradual reduction in the humoral immune response in smokers because of reduced 
expression of class I MHC by the alveolar macrophages in smokers (68,69).  
 Smokers show increased gingival recession and alveolar bone loss, greater 
periodontal ligament (PDL) attachment loss and deeper gingival pocket formation 
that is responsible for increased tooth mobility and tooth loss at an earlier age than 
non-smokers (70,71). Smoking has also been shown to reduce the concentration 
of serum IgG (25, 72,73).  Smoking is also known to alter the host inflammatory 
response to plaque bacteria. According to several studies, nicotine activates the 
anti-inflammatory pathway and suppresses pro-inflammatory cytokine production 
(74-78). Also there is reduced levels of pro-inflammatory cytokines, such as IL-1 
(84,85,86) in the gingival crevicular fluid (GCF) of smokers with periodontitis 
compared to non-smokers with periodontitis, whereas anti-inflammatory cytokines 
like IL-10 and TGF-β1 are increased in the GCF of smokers (79,80,81).  
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 Despite being more susceptible to periodontitis and exhibiting faster 
disease progression and severity, chronic smokers lack the clinically overt 
inflammatory response to bacterial plaque that non-smokers exhibit such as 
redness, swelling, bleeding on probing making diagnosis of the disease more 
complicated in smokers (45,82). 
Porphyromonas gingivalis 
 Porphyromonas gingivalis is a Gram-negative, proteolytic, asaccharolytic 
anaerobe. Although this bacterium is a natural member of the oral microbiome, it 
can proliferate to high numbers in periodontal lesions and can be highly destructive 
(83,84,85). P. gingivalis is found in significantly higher numbers in smokers 
compared to non-smokers and the infection is more persistent (70,86). 
 The “red complex” bacteria Porphyromonas gingivalis, Treponema 
denticola, and Tannerella forsythia, are frequently isolated together and are 
strongly associated with advanced periodontal lesions (56,87-89), but according 
to recent studies periodontal diseases are caused by synergistic and dysbiotic 
microbial community rather than “select periopathogens”  such as “red complex” 
(88). So the concept of “red complex” has been superseded by the “Keystone 
pathogen” hypothesis, at least in mice. This indicates that certain low-abundance 
microbial pathogens can cause inflammatory disease by increasing the quantity of 
the normal microbiota and by changing its composition (88). For instance, 
Porphyromonas gingivalis has been shown to manipulate the native immune 
system of the host (90). By doing so, it was hypothesized that it not only facilitates 
its own survival and multiplication, but also that of the entire microbial community.  
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Intensive study has revealed multiple virulence factors which are responsible for 
the survival and pathogenesis of P. gingivalis. 
Major fimbrial antigen (FimA) 
 The major fimbriae of P. gingivalis are long, hair-like, peritrichous, adhesive, 
filamentous structures that project away from the cell surface (91). They are 
primarily comprised of a 41 kD protein (FimA, fimbrillin) encoded by the fimA gene 
(92). P. gingivalis fimbriae adhere to a wide variety of molecules and oral 
substrates, which include salivary molecules, such as proline-rich proteins, proline-
rich glycoproteins, statherins, oral epithelial cells, fibrinogen, fibronectin, 
lactoferrin, and bacteria, such as oral streptococci and Actinomyces species (93-
96). Long fimbriae interact with glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) allowing for localization of P. gingivalis on the streptococcal surface (97). 
Human GAPDH has also been shown to bind to long fimbriae (98).              
 Based on its nucleotide sequence variation, the fimA gene has been 
classified into six types (I, Ib, II, III, IV, V) (99,100). fimA genotypes II, Ib, and IV 
were shown to cause inflammatory changes in animal models (101,102,103). 
Recombinant protein of fimA genotype II is known to adhere to and invade human 
epithelial cells than fimA from other genotypes (104). In human Gingival epithelial 
cells (GECs) long fimbriae are also known to induce cytokines involved in bone 
resorption, such as tumor necrosis factor (TNF), interleukin-1b (IL-1b), IL-8, and 
IL-6 by stimulating nuclear factor-kB (NF-kB) via TLR 2 and CD14 (105, 106, 107).  
Minor fimbrial antigen (Mfa1) 
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 Short fimbriae (Mfa1 fimbriae) are homopolymers of a subunit protein 
encoded by the mfa1 gene, with a molecular mass of 75 kDa (92,108). They are 
shorter than the major fimbriae and can be easily seen when the latter are absent 
(101). Short fimbriae mediate co-adhesion between P. gingivalis and S. gordonii 
via adhesin-receptor interactions with streptococcal SspA and SspB surface 
proteins (109). Studies have reported that short fimbriae induced the expressions 
of cytokines, including IL-1α, IL-1β, IL-6, and TNF, in both human monocytic cell 
lines and mouse macrophages by interacting with TLR2 and CD14 (110,111). 
Capsule 
 The P. gingivalis capsule is composed of glycosamionglycans and plays an 
important role in providing resistance to stressful conditions (112). It can help 
shield the microbe from the host defense and modulate host physiology (113) by 
providing resistance against neutrophils (114) and complement-mediated lysis or 
opsonization (115). The higher virulence potential of encapsulated strains 
compared to that of non-encapsulated ones, evaluated using a mouse abscess 
model, suggests that the capsule plays a significant role in the pathogenesis of this 
bacterium (116,117).  
 P. gingivalis capsule allows bacteria to escape host immune defenses by 
inhibiting the host immune response, thus promoting bacterial survival and growth 
(118). Recent studies show that encapsulated P. gingivalis strains trigger different 
host responses than non-encapsulated mutant strains (119,120). P. gingivalis K1 
serotype capsular polysaccharide is capable of eliciting chemokine production 
from macrophages that in turn promote cell migration (121). Defensins, a small 
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antimicrobial peptides produced by host cells have a bactericidal effect. P. 
gingivalis capsule reduces the bactericidal effect of these peptides contributing to 
increased survival of the organism (122). The non-encapsulated PgC strain is less 
virulent than the encapsulated W50 strain, demonstrating that capsule plays a role 
in the virulence of P. gingivalis in the mouse abscess model (111). However, the 
role of capsule in the virulence of P. gingivalis is still vague. 
Lipopolysaccharides (LPS) 
 The outer leaflet on the outer membrane of Gram-negative bacteria is 
comprised of lipopolysaccharide (123), which is atleast 10 kDa in size (84) 
Components of lipopolysaccharide are O-antigen, core, and lipid A. Lipid A is 
responsible for endotoxic activity, while the O-antigen is responsible for significant 
immunobiological activity (124) and is the easiest target for the humoral response 
of the host. The O antigen is recognized by the innate immune response and 
participates in complement activation (125,126). Many studies have established 
the immunobiological importance of the lipopolysaccharide of Gram negative cell 
wall envelope (127,128). It has the ability to activate the host inflammatory 
responses and disrupt bone remodeling process (129,130). P. gingivalis LPS binds 
to the CD14 and TLR-4, activating macrophages, epithelial cells respectively, 
leading to secretion of pro-infammatory cytokines (131,132).  
 P. gingivalis is known to show an unusual amount of lipid A heterogenicity 
containing both tetra-acylated and penta-acylated structures (134). Compared to 
E. coli, P. gingivalis Lipid A is heterogenic with varying numbers and positions of 
phosphate and fatty acid groups (134). When human monocytes were stimulated 
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with P. gingivalis LPS, the level of TNF, IL-1β and IL-6 was enhanced (133). LPS 
in P. gingivalis also plays a critical role in inducing cells to secrete pro-inflammatory 
cytokines, which mediate inflammation and participate in periodontal connective 
tissue destruction and alveolar bone resorption. P. gingivalis LPS is significantly 
less inflammatory than other Gram negative bacterial LPS such as that of E. coli. 
This might be because of differences in lipid A structure, reduced 4′ 
phosphorylation, reduced acylation at the 3 and 3′ positions on the back bone and 
the absence of acyloxyacyl group at the 3′ position (135). 
Proteases including gingipains 
 The classification of the proteases has relied upon their catalytic 
mechanisms. There are four categories of P. gingivalis proteases: serine, cysteine 
and metalloproteinase. These include gingipains (Arg- or Lys-), periodontain 
(cysteine endopeptidase), PrtT proteinase, Tpr proteinase, collagenase (prtC 
gene), prolyl tripeptidyl peptidase (serine exopeptidase), dipeptidyl-peptidase IV 
(serine exopeptidase known as glycylprolyl peptidase, a product of the dppIV 
gene), dipeptidyl-peptidase VI (putative cysteine exopeptidase), amino-peptidase 
P, oligo-peptidase O and gelatinase (a proteinase degrading type IV collagen, 
gelatin, low-molecular-mass-kininogen and transferrin) (136). Of these, the 
collagenases, aminopeptidases, and the trypsin-like proteases are critical to P. 
gingivalis pathogenesis (137).  
 Gingipains are cysteine proteases that can cleave the proteins at arginine 
and lysine specific sites (138). All the extracellular and cell-associated protease 
activity with specificity for arginine peptide bonds is derived from two genes, rgpA 
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and rgpB. All the extra- cellular activity with specificity for lysine peptide bonds is 
derived from a single gene, kgp (139). These are important etiological agents in 
periodontal diseases.  
 P. gingivalis proteases degradae and metabolise the extracellular matrix 
proteins (137). Gingipains have collagenolytic activity and degrade or inactivate 
inflammatory cytokines IL-6, IL-8, TNF and IFN. Proteases (Trp, PrtT) have MMP-
activating or hemagglutinating properties. Dipeptidyl amino- peptidase IV (DPPIV) 
may also act as a virulence factor by contributing to the degradation of connective 
tissue (140,141).  
Filifactor alocis 
 F. alocis is a Gram-positive, slow-growing, asaccharolytic, obligate 
anaerobic rod (142). It was first isolated in 1985 in the gingival sulcus of gingivitis 
and periodontitis patients and was classified as Fusobacterium alocis (143). Later, 
based on phylogenetic analysis of 16s rRNA, it was reclassified into the genus 
Filifactor (144). The size of the F. alocis genome is 1.93 Mb 
(www.broadinstitute.org). Cultivable strains of F. alocis include, ATCC 35896, D-
62D (clinical strain) (145) and CCUG 47790 T (www.straininfo.net). F. alocis is 
present in diseased periodontal pockets in higher numbers than in healthy mouths 
(146,147). Arginine, which increases the growth of F. alocis in vitro, is abundantly 
present in periodontal pockets (148). This has been hypothesized to help explain 
the presence of F. alocis in high numbers in periodontal pockets (149).  
 The gingival crevice is lined by epithelial cells, the first cells to be 
encountered by periodontal bacteria (150). Epithelial cells produce of the 
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chemoattractant cytokines like IL-8 which are responsible for signaling of the 
underlying tissues (151). Neutrophil migration into the gingival crevice is thought 
to be the first line of defense against plaque bacteria (152,153). F. alocis adheres 
to and invades the surface of gingival epithelial cells (GECs) (143). The secretion 
of proinflammatory cytokines IL-1, IL-6 and TNF by GECs are increased when 
infected with F. alocis (154). Such cytokines can induce osteoclastic activity and, 
thus, increased bone resorption (155). The effect of F. alocis on cell viability was 
investigated by observing the levels of apoptotic and necrotic cells after infection 
and it was confirmed that F. alocis stimulates apoptosis in GECs through the 
extrinsic apoptotic pathway, as it increases caspase-3 production (154). Transient 
activation of MEK1/2 and long term inhibition of MEK activity is caused by F. alocis. 
MEK1/2 activates MAPK pathways which can control cell proliferation and 
differentiation (154). Inhibition of MEK leads to induction of apoptosis in various 
cell types (156). Thus the pro-apoptotic effect of F. alocis is a result of its ability to 
inhibit MEK activity. All these effects of F. alocis on gingival cells may be 
responsible for the tissue destruction caused in periodontitis. 
Virulence factors of F. alocis 
Oxidative stress resistance 
 Periodontitis is characterized by the generation of reactive oxygen species 
(ROS) (166) by activated phagocytes at the gingival sulcus (157,158). ROS have 
the ability to initiate the destruction of connective tissue, and increasing ROS levels 
may kill different pathogens. So, oxidative stress resistance is important for the 
survival of an organism in the periodontal pocket (149). In broth culture, the 
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generation time was approximately 13 hours for F. alocis 35896 and 3 hours for P. 
gingivalis. When grown with 0.25mM of hydrogen peroxide to test their adaptation 
to oxidative stress (142), the generation time of F. alocis was 6 to 7 hours 
compared to 10 hours for P. gingivalis, which shows that F. alocis is more resistant 
to oxidative stress conditions than P. gingivalis. Also the growth of F.alocis 
appeared to be stimulated under such conditions (142). This might be another 
reason that helps explain the ability of F. alocis to thrive in the periodontal pocket 
(146). The exact mechanism underlying the oxidative stress resistance of F. alocis 
is not known. F. alocis has sialidase activity (142) which is important for the survival 
and pathogenesis of periodontal pathogens (160). This sialidase activity results in 
release of sialic acids that act as an ROS scavenger to reduce oxidative stress in 
the periodontal pocket (152). F. alocis has a putative neutrophil activating protein 
A (NapA). H. pylori NapA co-localizes with DNA, causing it to accumulate in one 
area of the bacterial cell protecting its DNA from damage by free radicals (161). 
There is a speculation that this neutrophil activating protein A may be an important 
virulence factor in F. alocis. It may also be responsible for the survival and 
stimulated growth of the bacteria under oxidative stress conditions (142) using a 
mechanism similar to that of H. pylori. Therefore, it is likely that the ability of F. 
alocis to survive oxidative stress in the periodontal pocket contributes to its ability 
to establish itself in this niche.  
Proteases 
 Proteases are important virulent factors of several oral pathogens (163). In 
Streptococcus mutans (164), Porphyromonas gingivalis (165) and Fusobacterium 
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nucleatum (166), proteome analysis has been used to understand the molecular 
mechanisms of bacterial invasion, survival and pathogenesis. When similar 
proteome analysis was performed in F. alocis ATCC 35896 and D-62D, strain-
specific variation in their protein profiles was observed and a few proteases that 
could potentially play an important role in the pathogenesis were identified (167). 
The F. alocis genome has a putative total of 15 different proteases. Both strains of 
F. alocis have CaaX proteases (167) which are known in S. gordonii for their role 
in protein transportation and protection from bacteriocins produced by other similar 
bacteria (168). Protease HMPREF0389_00122 is present in the extracellular 
fraction of the D-62D strain and is known to have a collagen peptidase function. 
This protease might be responsible for the damage of the connective tissue which 
leads to tissue destruction in periodontitis (167). So this could be important in F. 
alocis pathogenesis. Proteins that play a crucial role in the amino acid metabolism 
are seen in F. alocis (142). Although F. alocis lacks some inherent amino acid 
synthesis pathways, the release of required amino acids through protein 
degradation with the help of these proteases and peptidases may be important for 
F. alocis survival. F. alocis has proteins responsible for ornithine catabolism and 
urea breakdown (167) and this well-developed nitrogen assimilatory pathway may 
also be involved in alternative amino acid synthesis pathways (169). So we can 
conclude that F. alocis has mechanisms to provide for its nutritional needs. One of 
the major virulence mechanisms in bacteria is their ability for extracellular secretion 
of proteins (170). Proteins involved in type-II secretory pathway, namely, Type IV 
pilus assembly protein (HMPREF0389_00426) and trigger factor 
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(HMPREF0389_01646), were also identified in the membrane fraction of the F. 
alocis ATCC 35896 (167). F. alocis D62-D proteins, leucotoxin translocation ATP-
binding protein, fibronectin-binding protein, type IV pilus assembly protein, fimbrial 
assembly protein, hemolysin III type calcium-binding protein, toxin-antitoxin 
component protein and Na +/H + antiporter protein (NAPA) homologous to K+/H ÷ 
antiporter (171), are considered virulence factors in other microorganisms (167). 
F. alocis also has glycolytic enzymes, such as phospho-glycerate mutase and 
glyceraldehyde 3-phosphate dehydrogenase, that are responsible for energy 
metabolism (167). These virulence proteins and glycolytic proteins might have 
protein moonlighting functions such as mediating binding of bacteria to proteins of 
the extracellular matrix (ECM) like fibronectin (172), which is important for bacterial 
virulence in several human pathogens. Moonlighting proteins are multifunctional 
proteins which perform multiple autonomous, often unrelated, functions (173). 
These proteins add another dimension to cellular complexity and benefit cells in 
several ways (174). In conclusion, all of these proteins seen in F. alocis may 
contribute to its virulence but the exact role of these systems in the bacterial 
community is not clearly known. 
Treponema denticola 
 Treponema denticola is a helically shaped Gram-negative Spirochete that 
is motile and flexible. It has periplasmic flagella, which allow for mobility by using 
a proton motive force to cause thrusting through rotation (175). 
 Oral treponemes are a part of the polymicrobial biofilm (176). They play an 
important role in the etiology of several chronic diseases like chronic periodontitis, 
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acute necrotizing ulcerative gingivitis and dental abscesses (177-180). 
Treponemes are present normal healthy individuals in low numbers (181).  
 T. denticola has an ability to bind with Fusobacterium (182,183), early 
colonizing Streptococcus crista (184), P. gingivalis and T. forsythia (185,186,187). 
When co-cultured, P. gingivalis and T. denticola form significantly increased biofilm 
formation compared with monoculture (185). These interactions may be important 
for T. denticola to colonize and persist during health.  
Virulence factors of T. denticola 
 Little is known about the virulence factors of T. denticola but they are 
believed to have features needed for adherence, invasion and damage of the 
periodontal tissues.  
Leucine-rich repeat proteins (Lrr) 
 A T. denticola leucine-rich repeat protein (LrrA) has recently been shown to 
play a role in binding to T. forsythia.  Also leucine-rich repeat protein in T. forsythia 
has been shown to be important for epithelial cell invasion and virulence in a 
mouse alveolar bone loss model (186-190) and is believed to have similar function 
in T. denticola. 
Dentilisin 
 Dentilisin is proposed to be a major virulence factor of T. denticola. It 
contributes to disease progression by disrupting or modulating intercellular host 
signaling pathways and degrading host cell matrix proteins (191). It also allows for 
penetration of epithelial cell layers by T. denticola through degradation of 
intercellular adhesion proteins (191) and modulates host cell immune responses 
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through degradation of interleukin-1β (IL-1β), IL-6, tumor necrosis factor alpha 
(TNF), and monocyte chemo attractant protein 1 (192,193). 
Major sheath protein (Msp) 
 Msp is an abundant protein in the T. denticola outer membrane. It has 
surface-exposed loops that are able to bind to a variety of host proteins (181). Msp 
has been proposed to mediate colonization of host tissues (194,195). It is also one 
of the immunodominant T. denticola antigens recognized by human serum 
antibodies (196). Msp interaction leads to actin remodeling and reorganization in 
host cells, which is likely how it impairs neutrophil chemotaxis and phagocytic 
activity (197-200). 
Lipoproteins  
 Lipoproteins are the most abundant membrane-associated proteins found 
in spirochetes, and T. denticola 35405 is predicted to have 166 of them, the highest 
number for any of the sequenced spirochetes (201). The role of these in T. 
denticola virulence is as yet unresolved, but they are likely to be responsible for 
epithelial cell binding and invasion, subversion of the complement cascade, or 
tissue invasion (202,203). 
Outer Membrane Vesicles (OMVs) 
 Initially, OMV were thought to be the result of random blebbing of the outer 
membrane, or sheath, producing small spherical vesicles of 50-100 nm in 
diameter. However, recent studies have revealed that OMVs are formed by a 
highly regulated process which may increase the fitness of the bacterium in 
response to environmental stress (204,205,206). OMVs are considered potent 
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virulence factors, since they possess adhesins, toxins, and proteolytic enzymes 
that can mediate bacterial aggregation and invasion and can modulate the host 
immune response (205). T. denticola outer sheath vesicles (OSVs) can penetrate 
tissues more readily than the bacterium itself (207,208,209). Application of T. 
denticola OSVs to Hep-2 epithelial cell monolayers disrupted the tight junctions, 
which could facilitate penetration into underlying tissues (210). However, the 
involvement of treponemal OSVs in disease remains to be properly explored. 
Smoking and Periodontal Pathogens 
Tobacco-induced susceptibility to periodontitis was also believed to be associated 
with shifts in the microbial composition from one that is mainly constituted of Gram 
positive, aerobic, commensal bacteria to one that contains more Gram negative, 
anaerobic pathogens (211-218). Haffajee and Socransky (219) showed an 
increased prevalence of eight species, including P. gingivalis, in current smokers, 
while Eggert et al. (216) have shown a higher prevalence and proportion of T. 
forsythia, C. rectus, P. gingivalis and P. micros in plaque samples from smokers.  
A recent study done by Camello Castello et al.et al... (221), showed that there is 
an increased presence of Filifactor, Tanerella, Schwartzia, Bullleida and 
Anaeroglobus in chronic periodontitis patients who smoke compared to non-
smoking chronic periodontitis patients and non-smoking healthy individuals.  Also 
molecular studies have demonstrated that smokers with periodontitis have a 
diverse sub gingival microbial profile compared to non-smokers with periodontitis 
(198,200,201), which was contradicted in a recent study which showed that 
smokers with periodontitis has decreased bacterial diversity (221). 
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 According to Bagaitkar et al. (222), several functionally-related genes 
including multiple genes in the major fimbrial and capsular polysaccharide 
operons, as well as genes encoding transcriptional regulators; efflux pump and 
transport proteins; proteases and cell envelope proteins, were dysregulated when 
P. gingivalis W83 was exposed to cigarette smoke extract conditioned media using 
Microarray analysis (222). Also she found that cell surface or outer membrane 
proteins, i.e., RagA, RagB and PG0179 were shown by biochemical approaches 
to be present at higher levels after CSE treatment. But the genes encoding for 
these components were not identified as differentially expressed in her microarray 
experiments (222). This reflects inherent limitations in the microarray approach. 
However, till today, very little is known about how tobacco smoke affects the 





Cigarette smoke extract (CSE) represents an environmental stressor to which 
bacteria may adapt by several different mechanisms, one of which is by altering 
their gene expression. So, we hypothesize that established periodontal pathogens 
P. gingivalis, T. denticola and emerging periodontal pathogen F. alocis adapt to 
this environmental stress caused by cigarette smoke extract by altering their gene 
expression.
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CHAPTER 2: MATERIALS AND METHODS 
 
Bacterial Culture and in Vitro Modelling of Tobacco Exposure 
Porphyromonas gingivalis ATCC 33277, Filifactor alocis ATCC 35896 and 
Treponema denticola ATCC 35405 were purchased from the American Type 
Culture Collection (Manassas, VA) and maintained as frozen stocks.  Growth 
medium for P. gingivalis - Gifu anaerobic medium (GAM), was purchased from 
Nissui Pharmaceutical (Tokyo, Japan). Growth medium for F. alocis - Brain heart 
infusion (BHI), was purchased from Becton, Dickinson and Company (Sparks, MD) 
and infused with L-cysteine (0.1%) and arginine (20%) purchased from Sigma-
Aldrich (St. Louis, MO). Growth medium for T. denticola - Tryptone-yeast extract-
gelatin-volatile fatty acids-heat inactivated rabbit serum (TYGVS) (223). 3R4F 
standard reference cigarettes were obtained from the Kentucky Tobacco Research 
and Development Center (Lexington, KY).  All three media (GAM, BHI and 
TYGVS) were conditioned with cigarette smoke extract by drawing cigarette smoke 
through 50ml of the medium by using a three-way stopcock and a syringe, with 
35ml drags performed every 20 seconds. This cigarette smoke extract conditioned 
medium was then filtered (0.2mm). Nicotine content was determined by gas-liquid 
chromatography and adjusted to 7.2 pH and 1000 ng/ml nicotine concentration.
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 P. gingivalis, F. alocis, and T. denticola were grown in their respective 
control and cigarette smoke extract conditioned media under anaerobic conditions 
(80% N2, 10% H2, 10% CO2) at 370c. For all experiments, bacteria were grown 
either in control or CSE conditioned media and bacterial cells were harvested at 
mid to late log phase (P. gingivalis- O.D 600 nm =1.0, corresponding to 109 cells 
per ml; F. alocis- O.D 600nm =0.35, corresponding to 3×109 cells per ml;                        
T. denticola- O.D 600 nm = 1.6, corresponding to 8×109 cells per ml). 
Isolation of Total RNA 
Total RNA was isolated from bacterial cells according to manufacturer’s 
instructions using one of two kits. Perfect Pure TM RNA Cultured Cell Kit by 5 Prime 
(Gaithersburg, MD) was used for P. gingivalis and T. denticola. RiboPure TM –
Bacteria by Ambion life sciences (Thermofisher, Waltham, MA) was used for the 
Gram positive F. alocis. Gram positive bacteria require an additional step to break 
the thick peptidoglycan layer. The quantity and quality of RNA was measured by 
performing a Nanodrop on a ND-1000 Spectrophotometer and then samples of 
RNA were stored at -800C. 
RNA-seq Analysis 
Total RNA samples of P. gingivalis, F. alocis and T. denticola were sent to 
University of Michigan for RNA-Seq analysis. They first removed rRNA using a 
Ribo-zero rRNA removal kit by Epicentre (Chicago, IL). TruSeq RNA (non- 
stranded) kit by Illumina (Madison, WI) was used to generate m-RNA focused 
libraries. Once the libraries were generated, they were sequenced on 2 lanes using 
50bp single end reads. These raw reads were then sent to University of Michigan 
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Bioinformatics core, where quality of the reads was checked using FastQC 
(version 0.10.1). Tuxedo Suite software was used for alignment, differential 
expression analysis and post-analysis diagnostics. Bowtie2 (version 2.1.0) was 
used to align reads to the respective reference genome. FastQC was used for a 
second round of quality control (post-alignment), to ensure that only high quality 
data would be input to expression quantitation and differential expression analysis. 
Cufflinks/CuffDiff (version 2.1.1) was used for expression quantitation and 
differential expression analysis and CummeRbund was used to generate 
diagnostic plots. Genes having ≥1.5-fold change were classified as up regulated 
genes and genes with ≤0.6-fold change were classified as down regulated genes.  
Enrichment Analysis of RNA-Seq data 
KEGG and DAVID enrichment analysis were done on the differentially expressed 
P. gingivalis and F. alocis genes to identify significantly enriched functional 
categories. 
Validation of RNA-Seq data 
Differentially expressed genes of interest were confirmed by quantitative PCR 
analysis using an Applied Biosystems 7500 Real Time PCR system. Primers were 
designed using the qPCR primer design software, Primer Quest, provided by 
Integrated DNA technologies (http://www.idtdna.com/Primerquest/Home/Index).  
Table 1: P. gingivalis oligonucleotide primers used for quantitative PCR 
 
Gene ID Forward primer 5'-3' Reverse primer 5'-3' 
PGN_1047 TTCCATAGCCAAACGTGTAGAG CTGAGAGCCAACCGATCATATT 
PGN_0295 GGGTTCACTCAGTGCTCAAA GAGCCATCCAAACACTCGATAG 
kgp AGGACAGGGTGAAGTTGTAATC GCCTGCTTCGAATGTGAAATC 
PGN_1367 CTCCGGGTAAGGCTGTTAATG CAGCCACTTGTCCACTTCTT 
PGN_1740 TGAATGAGGGAGGAGAGGATAC ATGGAGAATGGCTGCTTGAG 
	26	
 
Table 2: F. alocis oligonucleotide primers used for quantitative PCR 
 
Gene ID Forward primer 5'-3' Reverse primer 5'-3' 
HMPREF0389_00184 CCATAGAGGCGGAGGACTTA GCTCCTCACCATCAAGTACATAG 
HMPREF0389_00178 GATGCCTGCTTGATGAGTTTG GCTGAGATTGTGCCTGAAGTA 
HMPREF0389_00166 CTGACACCGACCATCATCAA GCGGTTCATAGTTCCCGATAA 
HMPREF0389_00226 GAAGGACCTGTGGCTATGATTT AGCCTTATTACCGAGTCCTACA 
HMPREF0389_00802 GAACAGTGGAAGAGGCGATAAG AAGCCACTCTCCTTCCCTAA 
HMPREF0389_01353 ATGGAAGAAGAAGGCTGTAAGG ACTCTCTATGCAACGGACAAG 
HMPREF0389_00799 CTAAGGGTCTGTTGCTGAATCT CTATGGCGAACCTCCTGTATTT 
HMPREF0389_00800 CCGACTCAGATTGTAGTGGAAA CAGCAAGCCATCTCCTTCTAA 
HMPREF0389_00155 ACATCATAGACAGCAGATATAGGG GTTGCCATTTCGAGAAGTCTG 
HMPREF0389_00186 GGGCAAATGGACCGAATAAC GCTTGGTGAAACGGGATTAC 
HMPREF0389_01079 TTGTCACCTTGCCGTTTCT CCAAGTGCCGCTCTGATATT 
HMPREF0389_00246 GCACCCTTTGAAGCCTTTATC CTCCTGTAGACTTTCACGATCC 
HMPREF0389_00154 ACTATCCATTATCTACAATGCTCCT TCTTGCCATATTCTTTCATCATCAG 
HMPREF0389_00969 TCGTTTCGGGAGCATTGG AAAGTTCTCCGCCTACCATAAC 
HMPREF0389_00162 AAGCAGAAGAGTGGCGAAA CCCATGTGAATTGTCGGTATTTG 
HMPREF0389_01096 GTTCTGGAGATGGGTGTTTCT CCCTCTGCCCTTATTACCATATT 
HMPREF0389_00644 AGGTCGTGGCTATGTTGATG GACTGTCTGCTGTTGGTTAGT 
HMPREF0389_01592 ACAGCCTTAATCGGTTCGAG CTCACTTATATCTTCTCCGCCTATC 
HMPREF0389_00823 GGCACATATTTCCGGTAAACTTC CTTTCTCCATGTGATACGACCT 
HMPREF0389_00879 TCGCAAGTCACTCAGGAAAG CTGTTCCGACACCTACCATAAT 
 
 
Primers were designed for the species specific 16s rRNA gene, which was our 
reference gene. 
PGN_1644 GGCTGAAGATGGAAGAGGTATC GATGGCGGGAAAGTTGTTTG 
upp AGATGCGCGATGTCACTATTC GGGTCATCTTCTTGCTGATCTC 
PGN_0134 TCCATCATCAACGCCAAGAG GGCCGAAAGAAGTCCGTATT 
PGN_0885 CACCCTATGCTTTGCCTCTT CGAAGGCTCATGGGTGAATAA 
PGN_0545 CCTCTTGCTTTGTACGACTATCT AGACTGGATCACTGCTTCTATTC 
RgpA GGACCGACGAAAGAAGATGATTA CTTCCACCACCTTCGCTTATAG 
PGN_0727 CCCTTTATGCTTGCGGTATTG AAGGAAGGCGGGTGATATTT 
PGN_1695 TAGGAGCATTGGATCAGAGTGGTG GAAAGCCGGAGAAGTAATCATCC 
RpoC CGAAGGTGTAGTGGAGAATGT CATAGGGAGCCATCGTCTTATC 
Dps CGCTGAAGAATGTGACCGATA TCAAATCCACCGTTACCTCATC 
PGN_0173 GGATCAAGTCGGAGTGGAATAC CTTTAGAGGGAGCCGACATAAC 
PGN_0175 GCGTATCCTCTCTGAAGTTGTT GGTATCCTCCGATGCGATATG 
PGN_1080 GTAACTATGCAGCCGGTATGA CGGCTTCGTCTATGTACTTCTT 
PGN_0724 AACTTCTCGGATGCCTTCTTAC CGCAAAGCCTCTTACCTCTT 
PGN_0660 TGGCTTATCGTGGCTCTTTC GGAGGATCTCTTCTGCATCAC 
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P. gingivalis 16s rRNA - F: TGTAGATGACTGATGGTGAAAACC    
                   R: ACGTCATCCCCACCTTCCTC 
F. alocis 16s rRNA -      F: CAGGTGGTTTAACAAGTTAGTGG  
                  R: CTAAGTTGTCCTTAGCTGTCTCG  
Primers were ordered from Biosynthesis (www.biosyn.com) and were 
reconstituted and stored at -200C. Total RNA (up to 1	μg) was reverse transcribed 
to cDNA using Superscript ® III- First Strand Synthesis Super Mix by Invitrogen 
(Waltham, MA) following manufacturer’s instructions and stored at -200C. SYBYR 
Green Master Mix for qPCR analysis was ordered from Quanta Biosciences 
(Gaithersburg, MD) and the manufacturer’s instructions were followed to set up a 
reaction. Reaction conditions used for qPCR were 500C for 2 minutes, 950C for 10 
minutes, and 950C for 15 seconds – 45 repetitions and 600C for 1 minute. An 
additional dissociation stage was added to check for validity of primers which 
included 950C for 15 seconds, 600C for 1 minute, 950C for 15 seconds and 600C 
for 15 seconds.  
Statistical Analysis 
All experiments were done in triplicate unless otherwise mentioned. Statistical 
significance between groups was evaluated by one-way nonparametric ANOVA 
and Fisher multiple comparison test. A probability value ˂ 0.001 was considered 
statistically significant. 
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CHAPTER 3: RESULTS 
Growth of (P. gingivalis, F. alocis and T. denticola) in CSE- conditioned media 
We compared the growth of bacteria in CSE-conditioned and non-conditioned 
medium in order to determine if 1000 ng/ml nicotine equivalency was toxic to P. 
gingivalis, T. denticola or F. alocis. Similar growth characteristics were observed 
for all three species at this concentration of CSE. As shown in Figures 2, 3 and 4, 
the bacteria can tolerate this dose of CSE. All further experiments were done at 
1000 ng/ml nicotine equivalency, a dose that is relevant to the concentration of 


































Growth curve of P. gingivalis in unconditioned GAM and CSE conditioned GAM. 
Triangles represent the growth of P. gingivalis in CSE conditioned media and 
squares represent the growth in GAM. Error bars represent the mean Standard 
deviation (SD) of 3 experiments. There were no statistically significant differences 
in the growth curves between experimental conditions. 
 
Figure 3: Effect of CSE on F. alocis growth 
Growth curve of F. alocis in unconditioned BHI and CSE conditioned BHI. 
Triangles represent the growth of F. alocis in CSE conditioned media and squares 
represent the growth in BHI. Error bars represent the mean Standard deviation 
(SD) of 3 experiments. There were no statistically significant differences in the 



























Figure 4: Effect of CSE on T. denticola growth 
Growth curve of T. denticola in unconditioned TYGVS and CSE conditioned 
TYGVS. Triangles represent the growth of T. denticola in CSE conditioned media 
and squares represent the growth in TYGVS. Error bars represent the mean 
Standard deviation (SD) of 3 experiments. There were no statistically significant 
differences in the growth curves between experimental conditions. 
P. gingivalis differentially expressed genes 
RNA-Seq analysis was performed in order to determine the differentially expressed 
genes of P. gingivalis when exposed to CSE. A total of 644 were found to be 
differentially expressed (P < 0.005). 54 genes were up regulated and 590 genes 




























 Up regulated genes (> 1.5 fold) include the arginine and lysine gingipain 
encoding genes, kgp, rgpA and rgpB; genes encoding arginine and proline 
metabolism (PGN_1367, PGN_ 0504 and PGN_1434); genes encoding DNA 
binding (PGN_1740, dps and rpoC); a group of genes responsible for carbohydrate 
and energy metabolism, these include nitrogen metabolism (PGN_1047 and 
PGN_1367) and several genes encoding carbohydrate metabolism ( PGN_1695, 
PGN_0173, PGN_1753, PGN_0504, PGN_1529 and PGN_1755).  
Table 3: List of up regulated genes in P. gingivalis upon CSE exposure 
Gene ID Gene name Gene ID Gene name Gene ID Gene name 




PGN_1172  acyl-CoA dehydrogenase 





PGN_1000  glycine cleavage system protein H 
PGN_0295  
 C-terminal domain of 
Arg- and Lys-gingipain 
proteinase 
PGN_0731  hypothetical protein PGN_0099  peptidase 
kgp  Lys-gingipain PGN_0503  biotin carboxyl carrier protein PGN_0301  outer membrane protein 
PGN_1367  glutamate dehydrogenase PGN_1048  hypothetical protein PGN_1014  elongation factor G 
PGN_1740  RNA polymerase ECF-type sigma factor ustA  
upregulated in 
stationary phase 
protein A  
PGN_1752  ferredoxin 4Fe-4S 




PGN_1174  electron transfer flavoprotein alpha subunit 





PGN_1419  hypothetical protein 
PGN_1695  fructose-1,6-bisphosphate aldolase PGN_0033  thioredoxin PGN_2065  
Lys- and Rgp- gingipain 
domain protein 
rpoC  















dehydrogenase type I 
PGN_1434  aminoacyl-histidine dipeptidase PGN_0498  
succinate 
dehydrogenase/fumarate 
reductase iron-sulfur subunit 
PGN_1753  2-ketoisovalerate ferredoxin reductase PGN_0805  hypothetical protein PGN_0809  TonB protein 
PGN_1080  branched-chain amino acid aminotransferase PGN_0806  
MotA/TolQ/ExbB 
proton channel protein PGN_1120  
NADPH-NAD 
transhydrogenase 
PGN_0649  hypothetical protein PGN_1418  pyruvate-flavodoxin oxidoreductase PGN_1739  
hypothetical protein 
(lipoprotein) 





PGN_1880  malate dehydrogenase PGN_1655  
electron transport complex 
RsxE subunit 
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PGN_1995  hypothetical protein aspA  aspartate ammonia-lyase PGN_1352  hypothetical protein 
 
Table shows gene ID number and name of all P. gingivalis genes that were up 
regulated (> 1.5 fold) when exposed to CSE conditioned media. 
 Down regulated genes (< 0.6 fold) include genes encoding proteins that 
may be involved in  DNA replication, recombination and repair (e.g., PGN_1216, 
PGN_2011, and PGN_0644); the transfer gene cluster (traJ, traK, traM, traA and 
traG); Several genes in the ABC transporter operons (e.g., PGN_1325, 
PGN_1324, PGN_0706, PGN_0707 and PGN_0708); minor fimbrial operon 
(mfa1); several operons of transposases and partial transposases; genes 
encoding nucleotide excision, repair and metabolism (PGN_0327, PGN_1706, 
PGN_0195); putative endonuclease gene (PGN_1801) and genes in the capsular 
biosynthesis locus (PGN_110 and PGN_1072).  
Table 4: List of down regulated genes in P. gingivalis upon CSE exposure 
Gene ID Gene name Gene ID Gene name Gene ID Gene name Gene ID Gene name 
PGN_1644  transposase in ISPg1 PGN_0210  transposase in ISPg1 PGN_0385  integrase/recombinase XerD PGN_0196  
xanthine/uracil 
permease 
uvrC   excinuclease ABC subunit C  PGN_0706  
exported periplasmic 
protein PGN_0405  
alpha-1,2-
mannosidase PGN_0439  hypothetical protein  
PGN_1526  hypothetical protein PGN_0206  lipid A disaccharide synthase PGN_2013  
cation efflux system 
protein PGN_1024  
ribosome-binding 
factor A 
PGN_0820  hypothetical protein PGN_1627  4-amino-4-deoxy-L-arabinose transferase PGN_0549  
dTDP-glucose 4,6-
dehydratase PGN_1324  
ABC transporter 
membrane protein 
PGN_1713   PAP2 superfamily protein  PGN_0524  PAP2 superfamily protein PGN_1669  transposase in ISPg1 PGN_0738  phosphoglycerate mutase 




traJ  conjugate transposon protein TraJ  PGN_1491  hypothetical protein  
PGN_0134  biotin synthetase PGN_1901  transposase in ISPg1 PGN_0324  transposase in ISPg1 PGN_1586  hypothetical protein  
PGN_1177  transposase in ISPg1 PGN_1132  transposase in ISPg1 PGN_0056  conjugate transposon protein PGN_0688  hypothetical protein  
PGN_0885  nitroimidazole resistance protein PGN_1984  hypothetical protein PGN_1794  
hypothetical protein 




PGN_0216  hypothetical protein PGN_1216  transposase in ISPg1 PGN_1337  hypothetical protein PGN_t0049  tRNA-Ala 
PGN_0545  sulfatase PGN_0153  hypothetical protein PGN_1957  transposase in ISPg1 PGN_t0014  tRNA-Ala 




PGN_0260  hypothetical protein PGN_0959  transcriptional regulator 
PGN_0220  partial transposase in ISPg1 PGN_1511  hemolysin PGN_0971  transposase in ISPg1 PGN_1929  hypothetical protein  
PGN_0148  hypothetical protein PGN_0058  conjugate transposon protein PGN_1899  
hypothetical protein 




PGN_0966  partial transposase in ISPg1 PGN_1886  
NAD dependent 
epimerase PGN_1831  
ribosome-associated 
GTPase PGN_1950  hypothetical protein  
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PGN_1077  transposase in ISPg1 PGN_1455  hypothetical protein PGN_1309  ferrous iron transport protein B PGN_0777  
glycosyl 
transferase 
PGN_1456  hypothetical protein PGN_0490  DNA-damage-inducible protein F PGN_0858  
ABC transporter ATP-










8  tRNA-Arg PGN_1276  
transposase in 
ISPg1 
PGN_0807  DNAse related protein PGN_2009  hypothetical protein PGN_1110  partial transposase in ISPg1 trmE  
tRNA modification 
GTPase TrmE 
PGN_0810  hypothetical protein PGN_1568  hypothetical protein PGN_0832  gliding motility protein SprA PGN_1724  
glycosyl 
transferase group 2 
family protein  
PGN_2030   hypothetical protein (membrane protein) PGN_1645  dipeptidyl-peptidase III PGN_1300  
transcriptional 
regulator rnhB   ribonuclease HII  
PGN_1044  alpha-amylase PGN_0967  partial transposase in ISPg1 PGN_1734  
nucleoside permease 
NupG PGN_0406  
alpha-1,2-
mannosidase 
family protein  




helix protein ) 
PGN_0797  hypothetical protein PGN_1025  hypothetical protein PGN_1668  glycosyl transferase group 2 family protein  PGN_1161  
transposase in 
ISPg1 
PGN_1583  hypothetical protein PGN_1383  hypothetical protein (DNA alkylation repair protein) PGN_0587  transposase in ISPg1 PGN_1213  
ATP-binding 
protein 
PGN_0104  transposase in ISPg1 PGN_0379  hypothetical protein traM  conjugate transposon protein TraM PGN_1365  hypothetical protein 
PGN_1471  hypothetical protein  PGN_0240  ferrochelatase PGN_1539  ABC transport system exported protein 
PGN_t005
2  tRNA-Gly 




traK  conjugal transfer protein TraA PGN_1822  hypothetical protein 
PGN_t005
3  tRNA-Cys PGN_0716  
ABC transporter 
permease 
PGN_0242  glycosyl transferase family 1 PGN_1039  alpha-1,2-mannosidase PGN_1636  hypothetical protein  PGN_1723  hypothetical protein 





PGN_0070  hypothetical protein  gmk  guanylate kinase  PGN_1207  transport multidrug efflux protein 
PGN_0956  hypothetical protein PGN_1258  cobalamin biosynthesis protein 
PGN_t002
2  tRNA-Gly PGN_1797  hypothetical protein 





PGN_1325  ABC transporter membrane protein 





4  tRNA-Pro 
PGN_t004
6  tRNA-Asp PGN_1211  hypothetical protein PGN_1967  sulfatase lacZI  beta-galactosidase 
PGN_t001
8  tRNA-Leu PGN_0212  transposase in ISPg1 PGN_2050  
ATP-dependent 




PGN_1897  transport related membrane protein PGN_1956  putative DNA methylase  PGN_1838  
partial transposase in 
ISPg1 PGN_2090  hypothetical protein 
PGN_1378  replicative DNA helicase PGN_1389  acetyltransferase PGN_1215  hypothetical protein PGN_1952  hypothetical protein 
PGN_1198  sodium-solute transporter PGN_0435  partial hemagglutinin-related protein PGN_1896  sugar transferase PGN_0770  ribonuclease Z 
PGN_0707  iron ABC transporter permease PGN_1629  hypothetical protein traG  
conjugate transposon 




PGN_1708  magnesium chelatase subunit ChlI PGN_1487  dephospho-CoA kinase PGN_0425  
partial transposase in 
ISPg3 PGN_1821  
putative integrin 
subunit alpha  
PGN_1421  hypothetical protein PGN_1474  S-ribosylhomocysteinase PGN_0798  hypothetical protein PGN_1747  hypothetical protein  
PGN_0332  hypothetical protein PGN_0855  hypothetical protein PGN_t0038  tRNA-Leu PGN_0194  hypothetical protein 
PGN_1538  cation efflux system PGN_1528  NOL1/NOP2/sun family protein  PGN_1145  hypothetical protein  PGN_1074  
DNA 
methyltransferase  




PGN_1185  acetyltransferase  PGN_1195  hypothetical protein  
PGN_2066  ABC transporter ATP-binding protein PGN_2001  sensor histidine kinase PGN_1690  exported fucosidase PGN_0633  yadS protein    
PGN_2028  hypothetical protein PGN_0575  transposase in ISPg1 PGN_0686  iron ABC transporter permease PGN_0859  
ABC transporter 
permease protein 
PGN_0644  transposase in ISPg1 PGN_1087  hypothetical protein  PGN_1766  hypothetical protein PGN_0519  competence protein 
PGN_0325  hypothetical protein PGN_0986  hypothetical protein PGN_1584  potassium/proton antiporter PGN_1295  hypothetical protein 
PGN_0870  rod shape-determining protein RodA PGN_0162  hypothetical protein PGN_1765  hypothetical protein prtQ  PrtQ, protease  




PGN_0030  beta-mannosidase PGN_1481  polysaccharide biosynthesis protein PGN_0617  hypothetical protein PGN_0689  hypothetical protein 
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PGN_1214  RHS repeat-associated core domain protein  PGN_1222  hypothetical protein  PGN_1499  hypothetical protein PGN_1719  
Appr-1-p 
processing protein  
PGN_0708  iron ABC transporter ATP-binding protein PGN_0074  hypothetical protein PGN_1332  
para-aminobenzoate 







PGN_1322  hypothetical protein  PGN_0130  partial transposase in ISPg1 PGN_0311  hypothetical protein PGN_1731  hypothetical protein 




PGN_1653  thiamine biosynthesis lipoprotein ApbE PGN_1462  hypothetical protein 
PGN_0718  ABC transporter permease protein PGN_1923  hypothetical protein PGN_1535  hypothetical protein PGN_1459  hypothetical protein 
PGN_1029  GtrA family protein  PGN_1949  hypothetical protein PGN_0005  hypothetical protein PGN_1279  partial transposase in ISPg3 
PGN_0878  hypothetical protein PGN_0940  partial transposase in ISPg2 lacZII  beta-galactosidase  PGN_0111  
partial transposase 
in ISPg6 




PGN_0877  SNF2-related helicase PGN_1386  conjugative transposon TraJ protein PGN_0849  hypothetical protein PGN_0786  hypothetical protein 




PGN_1681  ABC transporter ATP-binding protein PGN_0307  TatD family protein  PGN_0908  hypothetical protein PGN_0032  hypothetical protein  
PGN_1083  hypothetical protein PGN_0003  hypothetical protein PGN_0703  hypothetical protein  PGN_1679  outer membrane protein 
PGN_2011  helicase PGN_0006  Na+driven multidrug efflux pump PGN_1801  
putative 




PGN_0750  copper homeostasis protein CutC PGN_1072  
glycosyl transferase 




PGN_1898  transport protein PGN_1310  glycogen synthase PGN_1100  capsule biosynthesis protein CapA PGN_1983  ion transporter 
PGN_1101  hypothetical protein  PGN_1944  hypothetical protein PGN_1725  polysaccharide deacetylase PGN_1013  
putative Fe-S 
oxidoreductase  
PGN_0270  amidophosphoribosyl-transferase PGN_0314  formate/nitrite transporter PGN_1404  hypothetical protein PGN_0869  
penicillin-binding 
protein 2 
PGN_1985  N-acetylmuramoyl-L-alanine amidase PGN_0699  hypothetical protein PGN_1559  hypothetical protein PGN_1267  SerB family protein  
PGN_0327  DNA polymerase III epsilon chain PGN_1008  
partial transposase in 
ISPg1 PGN_0230  
serine 
acetyltransferase PGN_1084  hypothetical protein 




PGN_1931  CRISPR-associated Cmr3 family protein  PGN_0554  hypothetical protein PGN_0436  
partial hemagglutinin-




0  tRNA-Pro PGN_0147  putative lipoprotein   PGN_0071  
 PF11888 domain 
protein   PGN_0979  hypothetical protein 








5  tRNA-His 
PGN_1076  DNA methylase PGN_0579  hypothetical protein PGN_0132  hypothetical protein PGN_1427  hypothetical protein 
PGN_0961  hypothetical protein PGN_1919  hypothetical protein PGN_1307  hypothetical protein PGN_0926  hypothetical protein 

























PGN_0352  hypothetical protein 




n III oxidase 
truA  tRNA pseudouridine synthase A  PGN_1290  hypothetical protein PGN_0107  
partial transposase in 
ISPg3 PGN_0835  hypothetical protein 
PGN_1932  CRISPR-associated Csm1 family protein PGN_0943  
alginate O-








PGN_0539  metallo-beta-lactamase superfamily protein PGN_1925  
CRISPR-associated Cas1 
family protein PGN_1248  hypothetical protein  PGN_0745  hypothetical protein 
PGN_0164  hypothetical protein PGN_0340  carboxyl-terminal processing protease PGN_0479  hypothetical protein PGN_1133  hypothetical protein 
PGN_1738  long-chain-fatty-acid-CoA ligase PGN_0542  
partial transposase in 
ISPg2 PGN_0596  
conjugate transposon 
protein PGN_0098  hypothetical protein 









PGN_0166  hypothetical protein (transposase) PGN_1073  hypothetical protein PGN_1730  hypothetical protein porS  
membrane protein 
PorS 
PGN_1940  MazG nucleotide pyrophosphohydrolase  PGN_0771  NLP/P60 family protein PGN_1665  hypothetical protein PGN_1147  hypothetical protein 
PGN_0014  hypothetical protein PGN_1070  hypothetical protein xseA  exodeoxyribonuclease VII large subunit PGN_1824  
putative integrin 
subunit alpha 
PGN_0582  DNA topoisomerase I PGN_1071  methylthioribose kinase  PGN_0308  hypothetical protein PGN_0018  hypothetical protein 
PGN_1527  tetrapyrrole methylase                  PGN_0146  hypothetical protein  PGN_0431  hypothetical protein PGN_0863  DNA methylase N-4/N-6 
PGN_0046  hypothetical protein PGN_1250  hypothetical protein PGN_1682  ABC transporter permease protein PGN_1387  
ABC transporter 
permease protein; 
PGN_0342  uracil-DNA glycosylase PGN_1680  ABC transporter permease protein PGN_1495  
low-specificity L-
threonine aldolase PGN_1336  putative lipoprotein  
PGN_0151  hypothetical protein PGN_0923  DNA primase PGN_0469  biotin synthesis protein 
PGN_t002
3  tRNA-Asp 
PGN_1030  hypothetical protein PGN_1201  tRNA (adenine-N6)-methyltransferase  PGN_0536  hypothetical protein PGN_0338  hypothetical protein 
PGN_0862  Type III restriction enzyme, res subunit PGN_0845  hypothetical protein PGN_1907  hypothetical protein PGN_0480  
partial transposase 
in ISPg4 
PGN_0086  DNA methylase PGN_1953  TonB-dependent outer membrane receptor 
PGN_t000
5  tRNA-Val PGN_1534  hypothetical protein 
PGN_0417  hypothetical protein PGN_1683  ABC transporter permease protein PGN_0565  hypothetical protein PGN_0822  hypothetical protein 
PGN_1223  uracil permease PGN_0922  Virulence-associated protein E  PGN_0924  mobilization protein PGN_1306  hypothetical protein 
PGN_0051  hypothetical protein  PGN_1082  hypothetical protein  PGN_1920  hypothetical protein PGN_1064  transposase in ISPg3 
PGN_0584  topoisomerase  PGN_1473  hypothetical protein PGN_0600  conjugal transfer protein TraG  
PGN_t000
2  tRNA-Asn 
PGN_0581  topoisomerase  PGN_t0041  tRNA-Ser traQ  
conjugate transposon 
protein TraQ PGN_0538  hypothetical protein 
PGN_0362  hypothetical protein PGN_1046  DNA repair protein PGN_0787  hypothetical protein PGN_1144  hypothetical protein 
PGN_1234  hypothetical protein PGN_2084  TraJ family protein conjugative transpos  PGN_1918  hypothetical protein PGN_0048  PcfK-like protein 
PGN_0852  immunoreactive 47 kDa antigen PG97  PGN_2063  hypothetical protein  PGN_0588  hypothetical protein PGN_0555  hypothetical protein 
PGN_0050  hypothetical protein PGN_1461  spore maturation protein A/B PGN_0105  hypothetical protein PGN_0957  hypothetical protein 
PGN_1394  transposase in ISPg2 PGN_1292  anti-restriction protein PGN_0946  hypothetical protein PGN_1068  oxidoreductase domain protein   
PGN_0152  immunoreactive 61 kDa antigen PG91 traO  
conjugate transposon 
protein TraO PGN_1916  
ABC transporter ATP-
binding protein PGN_1609  hypothetical protein 
PGN_0839  transposase in ISPg2 PGN_1017  hypothetical protein PGN_0075  relaxase/mobilization nuclease domain p  PGN_1662  
partial transposase 
in ISPg3 
PGN_1924   CRISPR-associated Cas2 family protein  PGN_1257  hypothetical protein  PGN_0652  hypothetical protein PGN_0402  hypothetical protein 
PGN_0851  hypothetical protein PGN_1707  putative lipoprotein  PGN_1478  hypothetical protein  PGN_0442  transposase in ISPg3 




PGN_0947  hypothetical protein PGN_1291  conserved hypothetical protein related to phage PGN_0028  
calcium-transporting 





PGN_0383  transporter PGN_1069  hypothetical protein PGN_0306  hypothetical protein PGN_0953  transposase in ISPg3 
PGN_1825  hypothetical protein PGN_1217  hydroxylamine reductase  PGN_0958  hypothetical protein hmuR  TonB-dependent receptor HmuR 
PGN_1823  hypothetical protein PGN_0455  partial transposase Orf1 in ISPg5 PGN_1476  hypothetical protein PGN_1371  hypothetical protein 
PGN_1353  DNA alkylation repair enzyme  PGN_0460  
DNA-binding protein 




PGN_0601  hypothetical protein 
PGN_1089  methyltransferase PGN_1067  hypothetical protein PGN_0978  hypothetical protein PGN_0072  hypothetical protein 




PGN_1624  hypothetical protein PGN_1160  transposase in ISPg2 PGN_0441  htpG; heat shock protein 90 
PGN_r000
6  5S ribosomal RNA 
PGN_0825  hypothetical protein PGN_0950  ABC transporter ATP-binding protein 
PGN_t000
8  tRNA-Pro PGN_2036  hypothetical protein 




PGN_0909  transposase in ISPg3 PGN_1922   transposase in ISPg3 PGN_1921   transcriptional regulator PGN_0796  hypothetical protein 
PGN_1065  transposase in ISPg3 porR  porP protein PGN_1109  hypothetical protein  PGN_0363  hypothetical protein  
PGN_1490  precorrin-2 C20-methyltransferase PGN_1060   transposase in ISPg3 PGN_0856  
A/G-specific adenine 
glycosylase PGN_0552  hypothetical protein 
PGN_0948  hypothetical protein PGN_0954  partial transposase in ISPg6 PGN_0920   partial excisionase 
PGN_t001
7  tRNA-Ser 
PGN_0049  anti-restriction protein PGN_1684  hypothetical protein PGN_t0004  tRNA-Val PGN_1265  hypothetical protein 
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PGN_0454  transposase in ISPg3 PGN_1335  hypothetical protein PGN_1006  transposase in ISPg3 PGN_1228  hypothetical protein 
PGN_1911  transposase in ISPg3 PGN_t0024   tRNA-Phe PGN_1063  
partial transposase 
Orf2 in ISPg5 PGN_0846  hypothetical protein 
PGN_1592  hypothetical protein PGN_0879   transposase in ISPg3 PGN_0843  hypothetical protein PGN_t0045  tRNA-Lys 
PGN_0213  hypothetical protein PGN_0459   transposase in ISPg3 PGN_1334  hypothetical protein PGN_0578  conjugate transposon protein 
PGN_0790  transposase in ISPg3 PGN_0106  partial transposase in ISPg3 PGN_0305  hypothetical protein PGN_1294  hypothetical protein 





2  5S ribosomal RNA 
PGN_t002
7   tRNA-Met PGN_1729  acetyltransferase  PGN_0401  hypothetical protein PGN_0921  hypothetical protein 
PGN_0326  DNA-binding protein histone-like family PGN_2059  hypothetical protein  PGN_0850  hypothetical protein PGN_1237  hypothetical protein 
PGN_0934   transposase in ISPg3 PGN_0925  mobilization protein PGN_t0025  tRNA-Leu PGN_1477  hypothetical protein 
PGN_1066   transposase in ISPg3 PGN_0847  hypothetical protein  PGN_0019  hypothetical protein PGN_t0006  tRNA-Met 
PGN_0955   transposase in ISPg3 PGN_0475  hypothetical protein  PGN_t0007  tRNA-Met PGN_0364  hypothetical protein  
PGN_0558   transposase in ISPg3 PGN_0337  hypothetical protein  PGN_0474  hypothetical protein PGN_1778  hypothetical protein 
PGN_1278  partial transposase in ISPg3  PGN_1428  transposase in ISPg3 PGN_0574  hypothetical protein 
PGN_t001
9  tRNA-Arg 
PGN_0576  hypothetical protein PGN_1913  transposase in ISPg3 PGN_1414  hypothetical protein PGN_0551  hypothetical protein 
PGN_0944   transposase in ISPg3 PGN_1560  hypothetical protein  PGN_1266  hypothetical protein PGN_0853  hypothetical protein 
PGN_0585   transposase in ISPg3 PGN_1912  partial transposase in ISPg6 
PGN_r000
7  5S ribosomal RNA PGN_0821  hypothetical protein 
PGN_1836   transposase in ISPg3 PGN_0304  hypothetical protein PGN_r0003  5S ribosomal RNA PGN_0047  hypothetical protein 
PGN_0864   transposase in ISPg3 PGN_0589  hypothetical protein 
Table shows gene ID number and name of all P. gingivalis genes that were down 
regulated (< 0.6 fold) when exposed to CSE. 
 
Figure 5: P. gingivalis ATCC 33277 differentially expressed genes in CSE  
Genes differentially expressed in P. gingivalis were grouped into different 








A B C D E F G
Differentially expressed genes - P. gingivalis ATCC 33277
Up	regulated	genes Down	regulated	genes
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Metabolism; B. Genetic information processing; C. Environmental information 
processing; D. Transposases or partial transposases; E. DNA replication, 
recombination and repair; F. Others and G. hypothetical or conserved hypothetical 
proteins. Closed boxes represent up regulated genes in P. gingivalis (> 1.5 fold), 
when exposed to CSE and open boxes represent down regulated genes in P. 
gingivalis (< 0.6 fold),  when exposed to CSE. 
KEGG analysis for differentially expressed P. gingivalis genes 
KEGG analysis was done on differentially expressed P. gingivalis genes to group 
them into various functional categories. Genes in several essential pathways were 
found to be differentially expressed. KEGG orthology system was used to generate 
these pathways with increased number of differentially expressed genes, which 
include glycolysis, citrate cycle, pyruvate metabolism, biosyntehsis of amino acids, 
butanoate metabolism, ABC transporters and CAMP resistance pathway genes. 
Several genes related to citrate cycle (PGN_1418, PGN_1529, PGN_1753, 
PGN_1755, PGN_1880, PGN_0496, PGN_0498, PGN_1752, and PGN_1756), 
Figure 6; pyruvate metabolism (PGN_0504, PGN_1755, PGN_1753, PGN_1529, 
PGN_1418, PGN_1880, Figure 7); glycolysis (PGN_1695, PGN_0173, 
PGN_1418, PGN_1529, PGN_1753, PGN_1755, Figure 8); butanoate metabolism 
(PGN_0496, PGN_0498, PGN_0724, PGN_0727, PGN_1172, PGN_1418, 
PGN_1755, PGN_1753, PGN_1529, Figure 9); and cationic antimicrobial peptide 
(CAMP) resistance (rgpB and rgpA) (Figure 10) pathways were found to be up 
regulated in P. gingivalis upon CSE exposure. Genes related to ABC transporter 
pathway (PGN_1325, PGN_1324, PGN_1025, PGN_1387, PGN_1471, 
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PGN_0706, PGN_0686, PGN_0707, PGN_0708, Figure 11) were found to be 
down regulated when P. gingivalis was exposed to Cigarette smoke. In amino acid 
biosynthesis pathway a few genes (PGN_0173, PGN_1695 and PGN_1080) were 
up regulated and a few genes (PGN_1475, PGN_0230, PGN_1474 and 
PGN_1495) were down regulated (Figure 12). 
 
Figure 6: Citrate cycle pathway of P. gingivalis  
Generated using KEGG orthology system and red boxes show differentially 
regulated P. gingivalis genes involved in Citrate cycle when exposed to CSE.  
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Figure 7: Pyruvate metabolism pathway of P. gingivalis 
Generated using KEGG orthology system and red boxes show differentially 




Figure 8: Glycolysis pathway of P. gingivalis 
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Generated using KEGG orthology system and red boxes show differentially 
regulated P. gingivalis genes involved in Glycolysis when exposed to CSE.  
 
Generated using KEGG orthology system and red boxes show differentially 
regulated P. gingivalis genes involved in Glycolysis when exposed to CSE. 
 
Figure 9: Butanoate metabolism pathway of P. gingivalis  
Generated using KEGG orthology system and red boxes show differentially 




Figure 10: CAMP resistance pathway of P. gingivalis 
Generated using KEGG orthology system and red box shows differentially 







Figure 11: ABC transporter pathway of P. gingivalis  
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Generated using KEGG orthology system and red boxes show differentially 
regulated P. gingivalis ABC transporter genes when exposed to CSE.  
 
Figure 12: Biosynthesis of amino acids pathway of P. gingivalis 
Generated using KEGG orthology system and red boxes show differentially 
regulated P. gingivalis genes involved in amino acid biosynthesis when exposed 
to CSE. 
F. alocis differentially expressed genes 
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When F. alocis was exposed to CSE, 83 genes were found to be differentially 
expressed (P < 0.005); 72 genes were up regulated (> 1.5 fold) and 11 genes were 
down regulated (< 0.6 fold). Many of the 83 genes that were differentially 
expressed encode hypothetical proteins whose functions have yet to be 
determined. 
 Up regulated genes include DNA replication gene (HMPREF0389_0155); 
Transfer gene cluster (traE and traG); Genes in the ABC transporter operon 
(HMPREF0389_00895, HMPREF0389_00896, HMPREF0389_00897, 
HMPREF0389_01591, HMPREF0389_01592, HMPREF0389_01190, 
HMPREF0389_01191 and HMPREF0389_01281); gene encoding fimbrial 
assembly protein (HMPREF0389_00415); transcription regulator genes 
(HMPREF0389_00643, HMPREF0389_01102 and HMPREF0389_01590); gene 
encoding cell wall serine protease (HMPREF0389_00110); nucleotide metabolism 
gene (HMPREF0389_00826); genes responsible for Carbohydrate metabolism 
(HMPREF0389_00473 and HMPREF0389_00883) and energy metabolism 
(HMPREF0389_01302 and HMPREF0389_01303); gene encoding type IV pilus 
protein (HMPREF0389_00416); several genes for processing genetic information 
(e.g., HMPREF0389_00822, HMPREF0389_00821, HMPREF0389_00820, 
HMPREF0389_00819, HMPREF0389_00831, HMPREF0389_00830, 
HMPREF0389_00829, HMPREF0389_00828) 
Table 5: List of up regulated genes in F. alocis upon CSE exposure 
Gene ID Gene name Gene ID Gene name Gene ID Gene name 



















type IV conjugative 






HMPREF0389_00412  hypothetical 




HMPREF0389_01273  46unctional46l membrane protein 
HMPREF0389_00166  TnpX site-specific recombinase HMPREF0389_00825 
map; Methionine 
aminopeptidase HMPREF0389_01581  hlyD; hemolysin D 
HMPREF0389_00246  antirestriction protein (ArdA) HMPREF0389_00826  
adk; adenylate 








HMPREF0389_00415  fimbrial assembly protein PilN 
HMPREF0389_00969  nitrite transporter NirC HMPREF0389_00414  hypothetical HMPREF0389_03101  23S ribosomal RNA 
HMPREF0389_01685  hypothetical HMPREF0389_01102  transcriptional regulator, TetR HMPREF0389_00831  
50S ribosomal 
protein L18 




HMPREF0389_01537  hypothetical 
HMPREF0389_01096  MATE efflux family protein HMPREF0389_01590  
Transcriptional 
regulator, AraC HMPREF0389_03107  23S ribosomal RNA 
















HMPREF0389_00416  pilM; type IV pilus assembly protein 












HMPREF0389_01169  CRISPR-associated protein, Csd1 family 































HMPREF0389_03110  23S ribosomal RNA  HMPREF0389_01135  hypothetical 









HMPREF0389_00643  transcriptional regulator HMPREF0389_01138  
GTP binding 
protein HMPREF0389_00473  
pyruvate 
carboxylase 
HMPREF0389_00822  rpsM; 30S ribosomal protein S13 HMPREF0389_01110  
prtA: cell wall 
serine protease HMPREF0389_01189  
RND family efflux 
transporter MFP 
subunit 
HMPREF0389_00898  GNAT family acetyltransferase hypothetical    HMPREF0389_01137  
thiH; thiazole 
biosynthesis protein 
HMPREF0389_00821 rpsK; 30S ribosomal protein S11 HMPREF0389_00660  
NlpC/P60 family 
protein HMPREF0389_00959  
NADH oxidase, 
water-forming 
Table shows gene ID number and name of all F. alocis genes that were up 
regulated (> 1.5 fold) when exposed to CSE. 
 Down regulated genes include gene encoding nitrate/nitrite response 
regulator protein (HMPREF0389_00802); signal peptidase gene 
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(HMPREF0389_00799) and a gene responsible for glycolysis 
(HMPREF0389_00226).  
Table 6: List of down regulated genes in F. alocis upon CSE exposure 
Gene ID Gene name 
HMPREF0389_00226  acetyl coenzyme A synthetase 
HMPREF0389_00802  Nitrate/nitrite response regulator protein 
HMPREF0389_01749  hypothetical 





HMPREF0389_00799 signal peptidase I 
HMPREF0389_00801 hypothetical 
HMPREF0389_00800 low density lipoprotein receptor 2 
Table shows gene ID number and name of all F. alocis genes that were down 
regulated (< 0.6 fold) when exposed to CSE.  
 
Figure 13: F. alocis ATCC 35896 differentially expressed genes in CSE 
Genes differentially expressed in F. alocis were grouped into different functional 
categories using KEGG enrichment analysis software, A. Carbohydrate 










A B C D E F G H I J K
Differentially expressed genes in F. alocis ATCC 35896
Up	regulated	genes Down	regulated	genes
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metabolism; E. Metabolism of Cofactors and vitamins; F. Trancription; G. 
Translation; H. Folding, sorting and degradation; I. Membrane transport; J. 
Hypothetical proteins and K. Others. Closed boxes represent up regulated genes 
in F. alocis (> 1.5 fold), when exposed to CSE and open boxes represent down 
regulated genes in F. alocis (< 0.6 fold),  when exposed to CSE. 
KEGG analysis for differentially expressed F. alocis genes 
KEGG analysis was done on differentially expressed F. alocis genes to group them 
into various functional categories. Genes in several essential pathways were found 
to differentially expressed. KEGG orthology system was used to generate these 
pathways with increased number of differentially expressed genes, which include 
pyruvate metabolism, oxidative phosphorylation, ABC transporter, protein export 
and bacterial secretory system pathways. Genes related to oxidative 
phosphorylation (HMPREF0389_01302 and HMPREF0389_01303, Figure 14), 
ABC transporter (HMPREF0389_00896, HMPREF0389_00897 and 
HMPREF0389_00895, Figure 15) and bacterial secretory system 
(HMPREF0389_01581 and HMPREF0389_00827, Figure 16) pathways were up 
regulated when F. alocis was exposed to Cigarette smoke. In protein export 
pathway gene (HMPREF0389_00827) was up regulated and gene 
(HMPREF0389_00799) was down regulated (Figure 17). Similarly, in pyruvate 
metabolism pathway gene (HMPREF0389_00473) was up regulated and gene 




Figure 14: Oxidative phosphorylation pathway of F. alocis 
Generated using KEGG orthology system and red boxes show differentially 






Figure 15: ABC transporter pathway of F. alocis  
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Generated using KEGG orthology system and red boxes show differentially 
regulated F. alocis ABC transporter genes when exposed to CSE.  
 
 
Figure 16: Bacterial secretory system pathway of F. alocis 
Generated using KEGG orthology system and red boxes show differentially 





Figure 17: Protein export in F. alocis 
Generated using KEGG orthology system and red boxes show differentially 




Figure 18: Pyruvate metabolism pathway of F. alocis 
Generated using KEGG orthology system and red boxes show differentially 
regulated F. alocis genes involved in Pyruvate metabolism when exposed to CSE.  
T. denticola differentially expressed genes 
We were unable to efficiently isolate RNA from T. denticola, therefore differentially 
regulated genes could not be identified. 
Validation of RNA-Seq data by qPCR analysis 
To validate the RNA-Seq analysis, qPCR was performed on selected up regulated 
and down regulated genes for both F. alocis and P. gingivalis. As seen in Table 7 
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and Table 8, most of the selected genes showed trends similar to that of RNA-Seq 
analysis. However differential expression of only a small number of genes was 
statistically significant in the qPCR experiments. 
Table 7: qPCR expression values for selected P. gingivalis genes 
 













16s rRNA Reference gene 10.73 13.17 0.0001 
                                 Selected P. gingivalis up-regulated genes by qPCR analysis 
















PGN_1047a hydroxylamine reductase 4.77 3.09 -1.68 3.2 0.16 
PGN_0295a C-terminal domain of Arg- and Lys-gingipain proteinase 5.41 3.38 -2.03 4.08 0.23 
Kgpa Lys-gingipain 4.37 2.04 -2.33 5.02 0.58 
PGN_1367a glutamate dehydrogenase 4.75 2.86 -1.89 3.70 0.06 
PGN_1740a RNA polymerase ECF-type sigma factor 3.61 2.50 -1.11 2.15 0.2 
RgpAa RgpAc; glycosyltransferase 3.87 1.23 -2.64 6.23 0.125 
PGN_0727a 4-hydroxybutyryl-CoA dehydratase 3.29 0.98 -2.31 4.95 0.013
b 
PGN_1695a fructose-1,6-bisphosphate aldolase 3.52 1.12 -2.4 5.27 0.56 
RpoCa DNA-directed RNA polymerase subunit beta 4.25 1.28 -2.97 7.83 0.01
b 
Dpsa DNA-binding protein from starved cells Dps 4.07 1.17 -2.9 7.46 0.0009
b 
PGN_0173a glyceraldehyde 3-phosphate dehydrogenase type I 3.77 1.13 -2.64 6.23 0.035 
PGN_0175a 2-ketoisovalerate ferredoxin reductase 4.01 1.13 -2.88 7.36 0.022 
PGN_1080a branched-chain amino acid aminotransferase 3.66 1.1 -2.56 5.89 0.126 





4.13 1.24 -2.89 7.41 0.008* 
   Selected P. gingivalis down-regulated genes by qPCR analysis 
















PGN_1644 transposase in ISPg1 2.54 1.51 -1.03 2.04 0.01b 
Uppa uracil phosphoribosyltransferase 4.97 5.87 0.9 0.53 0.0003
b 
PGN_0134a biotin synthetase 5.53 5.89 0.36 0.77 0.001b 
PGN_0885 nitroimidazole resistance protein 5.83 5.79 -0.04 1.02 0.022
b 
PGN_0545 sulfatase 5.88 5.63 -0.25 1.18 0.056 
The table shows all P. gingivalis up-regulated and down-regulated genes from 
RNA-Seq selected for qPCR analysis. Positive DDCt values indicate more PCR 
cycles and therefore less targeted gene after CSE exposure, meaning suppression 
of targeted gene expression. Conversely, negative DDCt values indicate more 
targeted gene after CSE exposure, indicating induction of gene expression. 
 
a. Differentially expressed genes in qPCR which correlate with RNA-Seq results. 
b. Represents P. gingivalis genes that showed statistically significant (P< 0.05) 
difference in their expression when exposed to cigarette smoke in qPCR analysis. 
 
Table 8: qPCR expression values for selected F. alocis genes 
 
Gene ID Gene name 
Control 
qPCR expression value 
(Mean CT) 
CSE 






16srRNA Reference gene 10.54 11.23 0.16 
    Selected F. alocis up-regulated genes by qPCR analysis 

















HMPREF0389_00155 DNA replication protein DnaC 12.97 14.90 1.93 0.26 0.01
b 
HMPREF0389_00186a Nlpc/P60 family protein 15.47 14.7 -0.77 1.70 0.64 
HMPREF0389_00184a Type IV conjugative transfer protein TraE 15.79 14.65 -1.14 2.20 0.04
b 
HMPREF0389_00178 TraG family protein 15.66 15.74 0.08 0.94 0.03b 
HMPREF0389_00166a TnpX site-specific recombinase 14.38 13.28 -1.1 2.14 
 
0.13 
HMPREF0389_00246a Antirestriction protein (ArdA) 14.24 13.43 -0.81 1.75 0.50 
HMPREF0389_00154a Replication initiation protein 12.21 11.32 -0.89 1.85 0.71 
HMPREF0389_00969 Nitrate transporter NirC 8.41 9.1 0.69 0.61 0.01
b 
HMPREF0389_00162a Conjugation protein 13.26 12.58 -0.68 1.60 0.98 
HMPREF0389_01096a MATE efflux family protein 9.06 8.18 -0.88 1.84 0.84 






8.46 5.51 -2.95 7.72 0.01b 





10.78 10.41 -0.37 1.29 0.5 
HMPREF0389_01079 Iron-sulfur cluster-binding protein 10.56 11.66 1.1 0.46 0.1 
         Selected F. alocis down-regulated genes by qPCR analysis 
















HMPREF0389_00226a Acetyl coenzyme A synthetase 4.61 4.71 0.1 0.93 0.02 
HMPREF0389_00802 Nitrate/nitrite regulator protein 9.95 9.49 -0.46 1.37 0.27 
HMPREF0389_01353 Amidinotransferase 13.17 12.54 -0.63 1.54 0.75 





8.93 8.72 -0.21 1.15 0.09 
 
Table shows all F. alocis up regulated and down regulated genes from RNA-Seq 
selected for qPCR analysis. Positive DDCt values indicate more PCR cycles and 
therefore less targeted gene after CSE exposure, meaning suppression of targeted 
gene expression. Conversely, negative DDCt values indicate more targeted gene 
after CSE exposure, indicating induction of gene expression. 
 
a. Differentially expressed genes in qPCR which correlate with RNA-Seq results. 
b. Represents the F. alocis genes that showed statistically significant (P<0.5) 
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            CHAPTER 4: DISCUSSION 
 
Cigarette smoke is an important environmental risk factor for periodontal diseases. 
Also cigarette smoke is known to increase vulnerability to oral bacterial infection, 
but with reduced clinical signs of overt inflammation. The underlying mechanism 
for this response is not clearly established. However, we can hypothesize that 
cigarette smoke causes alterations in the gene expression in periodontal bacteria. 
In our RNA-Seq experiments we were able to find the differentially expressed 
genes in an established periodontal pathogen, P. gingivalis, and an emerging 
periodontal pathogen, F. alocis. Approximately, 30% of genes in P. gingivalis 
genome and 5% of genes in F. alocis genome were found to be differentially 
expressed when exposed to cigarette smoke.  
 In P. gingivalis several functionally related genes were found to be up 
regulated, including genes encoding arginine and lysine gingipains (kgp, rgpA and 
rgpB), DNA binding genes and genes responsible for carbohydrate and energy 
metabolism. Gingipains play an important role in multiple virulence mechanisms in 
P. gingivalis, which are responsible for the growth and survival of the bacterium. 
They protect P. gingivalis from phagocytosis by PMN’s by degrading macrophage 
CD14, thus inhibiting activation of leucocytes through the LPS receptor (138) and 
by degrading complement factor C3, preventing deposition of C3b on the bacterial 
cell surface (225,226). Also in addition to providing energy through degradation
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and metabolism of extracellular matrix proteins (227), they subvert the host 
response by degrading inflammatory cytokines, IL-6, IL-8 and TNF (136,138). DNA 
binding gene PGN_1740 is known to play a key role in biofilm formation by P. 
gingivalis (228). It has been demonstrated that the Dps (DNA-binding protein from 
starved cells) protein in E. coli plays an important role in the protection of cells from 
peroxide stress and is believed to have similar kind of function in P. gingivalis 
(229,230,231). Carbohydrate and amino acid metabolism provide P. gingivalis with 
energy necessary for its growth. 
 Several genes encoding proteins involved in DNA replication, 
recombination and repair which are essential genes for P. gingivalis; transfer (tra) 
genes which might be responsible for genomic diversity in P. gingivalis strains 
(232,233); ABC transport genes required for optimal entry of P. gingivalis into 
GECs (234); genes in the capsular biosynthesis locus (PGN_110 and PGN_1072) 
needed for capsule synthesis; minor fimbrial operon gene (mfa1)  which is known 
to play  key role in P. gingivalis auto-aggregation (235) and interspecies 
interactions with oral streptococci that facilitate biofilm formation (97,236), were 
found to be down regulated when P. gingivalis was exposed to cigarette smoke 
extract.  
 Many of the differentially expressed genes in F. alocis when exposed to 
CSE conditioned media encode hypothetical proteins whose function is yet to be 
determined. Several ABC transporter genes were found to be up regulated which 
are believed to provide resistance to P. gingivalis from potentially harmful 
chemicals in cigarette smoke (222) and might have similar function in F. alocis. 
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Transfer (tra) genes necessary for non-sexual transfer of genetic material in both 
Gram-positive and Gram-negative bacteria (237) and several genes processing 
genetic information were induced when exposed to cigarette smoke, suggesting 
the potential for increased genomic diversity among F. alocis strains. A fimbrial 
assembly gene (HMPREF0389_00415) which is known for its virulence in other 
bacteria like P. gingivalis, E. coli and also several carbohydrate and lipid 
metabolism genes that provide energy to the organism were found to be up 
regulated. Nitrate/nitrite response regulator protein (HMPREF0389_00802) 
needed for alternative mode of amino acid synthesis (169) was seen to be down 
regulated when exposed to cigarette smoke. 
 Even though all selected up regulated P. gingivalis genes from RNA-Seq 
showed up regulation (fold change > 1.5)  in their expression when exposed to 
CSE in qPCR analysis, there were only a few genes with significant (P≤0.01) 
differences, which include PGN_0724, dps, rpoC and PGN_0660. DNA- binding 
genes (dps and rpoC) were seen to show increased expression in both RNA-Seq 
and qPCR analysis when exposed to CSE. These proteins bind DNA and are 
known as histone-like proteins and are believed to have diversity of functions 
responsible for survival of the organism. Also as said earlier Dps (DNA-binding 
protein from starved cells) protein in E. coli plays an important role in the protection 
of cells from peroxide stress and might show similar function in P. gingivalis 
(222,223,224). PGN_0660 and PGN_0724 are oxidoreductases and increase in 
the expression of these gene may be involved in protecting the bacteria from 
oxidative stress generated in periodontal diseases.  
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 In contrast with our RNA-Seq data, only one gene Upp (uracil phospho 
ribosyl transferase) which might be responsible for cell wall organization and 
regulation of cell wall shape was found to be down regulated (Fold change < 0.6) 
in qPCR analysis.  
 Similar to RNA-Seq results most of the selected up regulated F. alocis 
genes from were found to be up regulated (Fold change >1.5)  in qPCR analysis, 
but only expression of few genes was statistically significant (P≤0.01) difference, 
which include HMPREF0389_00969 and HMPREF0389_01592. Formate/ Nitrate 
transporter protein (HMPREF0389_00969) may be necessary for the anaerobic 
respiration of F. alocis. ABC transporter protein (HMPREF0389_01592) was seen 
to be up regulated in both qPCR and RNA-Seq analysis of F. alocis genes. As said 
earlier, this gene is believed to responsible for protecting P. gingivalis from harmful 
chemicals of cigarette smoke (222) and it might have similar function in F. alocis. 
 In contrast with our RNA-Seq data, most of the selected F. alocis down 
regulated genes remain unaltered in qPCR analysis. One gene 
HMPREF0389_01353 (amidino transferase) found to be up regulated in qPCR and 
downregulated in RNA-Seq. It’s function in the virulence of F. alocis was yet to be 
determined. 
As stated earlier, expression of most of the selected genes for qPCR was similar 
to that of RNA-seq but not statistically significant (P≤0.01). This might be due to 
limitations in qPCR, like intra- and inter- assay variability (238) and/or complicated 
RNA-Seq technique. As statistical power is closely linked to sample size, a long 
transcript is more likely to be found differentially expressed during RNA-Seq than 
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a short transcript (240). So expression levels of short genes are not accurate with 
RNA-Seq analysis (239).  
 Also our RNA-seq data for P. gingivalis is not in agreement with the study 
done by Bagaitkar et al.. (222). Several genes responsible for growth and survival 
of P. gingivalis like genes responsible for DNA- replication, recombination and 
repair; ABC transporter genes which were found to be up regulated in her study, 
were down regulated in our study. Study done by Bagaitkar et al.. (222) was on P. 
gingvalis W83 strain, by using microarray analysis and at a CSE concentration of 
500 ng/ml nicotine equivalents. We used P. gingivalis ATCC 33277 and a CSE 
concentration of 1000 ng/ml nicotine equivalency and RNA sequencing. Therefore, 
genetic, dose and technical differences may each and all have contributed to 
variation in results between studies.  
 Future studies can be done on the key P. gingivalis and F. alocis 
differentially expressed genes (validated by qPCR), when exposed to CSE 
conditioned media, using	 site-directed mutagenesis and complement assays. 
These procedures provide better understanding of specific genes as well as for 
developing novel variants of gene of interest. These studies might also provide 
some of the first insights into how tobacco smoke changes the P. gingivalis and F. 
alocis phenotype in a manner likely to promote their colonization and infection. 
 In summary, smokers are more prone to bacterial infection and to develop 
periodontitis, yet exhibit reduced clinical inflammation. Our experimental results 
showed that several genes essential for growth and survival of P. gingivalis and F. 
alocis were differentially expressed when exposed to cigarette smoke. These 
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